Table: Actelion at a Glance
Founded in 1997 by four ex-Roche scientists. Now employs 400 at headquarters in the Swiss city of Basel and at subsidiaries in France, Germany, Italy, and the U.S.
QUICK TO MARKET
Succeeded in getting its pulmonary arterial hypertension drug, Tracleer, to market a scant four years after the company's founding, record time for a biotech company.
Projected 2002 sales of $66 million; expected to become profitable in 2004.
Data: Company reports, SG Cowen Securities Corp., BusinessWeek